Acadian Asset Management LLC Rigel Pharmaceuticals Inc Transaction History

Acadian Asset Management LLC

$32.5 Billion
Q2 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$1.12 - $1.57 $944,629 - $1.32 Million	843,419 Added 18.25%	5,465,183 $8.09 Million
Q4 2023 Feb 13, 2024	SELL	$0.72 - $1.56 $28,062 - $60,802	-38,976 Reduced 0.84%	4,621,764 $6.7 Million
Q3 2023 Nov 13, 2023	BUY	$1.07 - $1.39 $84,773 - $110,126	79,228 Added 1.73%	4,660,740 $5.03 Million
Q2 2023 Aug 07, 2023	BUY	$1.12 - $1.82 $960,902 - $1.56 Million	857,949 Added 23.04%	4,581,512 $5.91 Million
Q1 2023 May 11, 2023	BUY	$1.25 - $2.0 $227,577 - $364,124	182,062 Added 5.14%	3,723,563 $4.91 Million
Q4 2022 Feb 14, 2023	BUY	$0.67 - $11.9 $904,258 - $16.1 Million	1,349,640 Added 61.58%	3,541,501 $5.31 Million
Q3 2022 Nov 14, 2022	SELL	$1.1 - $12.2 $29,053 - $322,226	-26,412 Reduced 1.19%	2,191,861 $2.58 Million
Q2 2022 Aug 09, 2022	BUY	$0.67 - $3.19 $941,671 - $4.48 Million	1,405,480 Added 172.92%	2,218,273 $2.51 Million
Q1 2022 May 12, 2022	BUY	$2.22 - $3.45 $504,879 - $784,609	227,423 Added 38.85%	812,793 $2.43 Million
Q4 2021 Feb 10, 2022	BUY	$2.36 - $3.57 $1.38 Million - $2.09 Million	585,370 New	585,370 $1.55 Million
Q1 2021 May 11, 2021	SELL	$3.35 - $4.93 $568,277 - $836,300	-169,635 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$2.35 - $3.74 $2.44 Million - $3.88 Million	-1,036,696 Reduced 85.94%	169,635 $594,000
Q3 2020 Nov 09, 2020	SELL	$1.78 - $4.13 $364,406 - $845,505	-204,723 Reduced 14.51%	1,206,331 $2.9 Million
Q2 2020 Aug 12, 2020	BUY	$1.41 - $2.05 $137,506 - $199,920	97,522 Added 7.42%	1,411,054 $2.58 Million
Q1 2020 May 11, 2020	BUY	$1.27 - $3.0 $479,934 - $1.13 Million	377,901 Added 40.39%	1,313,532 $2.05 Million
Q4 2019 Feb 06, 2020	BUY	$1.6 - $2.43 $978,497 - $1.49 Million	611,561 Added 188.71%	935,631 $2 Million
Q3 2019 Nov 07, 2019	BUY	$1.63 - $2.62 $113,754 - $182,844	69,788 Added 27.45%	324,070 $606,000
Q2 2019 Aug 08, 2019	BUY	$2.02 - $2.61 $434,417 - $561,301	215,058 Added 548.28%	254,282 $663,000
Q1 2019 May 09, 2019	BUY	$2.0 - $2.65 $78,448 - $103,943	39,224 New	39,224 $101,000

Others Institutions Holding RIGL

# of Institutions

Shares Held

355K

Call Options Held

Put Options Held

View Full List

About RIGEL PHARMACEUTICALS INC

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.77B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

More about RIGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.

Account